| Arif Husain, MD | |
|
3505 Western Ave, Kingman, AZ 86409-3071 | |
| (928) 757-8111 | |
| (928) 757-1199 |
| Full Name | Arif Husain |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 45 Years |
| Location | 3505 Western Ave, Kingman, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043276918 | NPI | - | NPPES |
| 260041671 | Other | PA | RAIL ROAD |
| 0015970290008 | Medicaid | PA | |
| 314995 | Medicaid | AZ | |
| 260045486 | Other | PA | PALMETTO GBA |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reading Behavioral Healthcare, Llc | 8527495183 | 17 |
News Archive
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The U.S. Food and Drug Administration today unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics.
More aggressive treatment with statins is necessary to lower LDL (low-density lipoprotein) cholesterol in patients with coronary heart disease and metabolic syndrome, a syndrome composing of three cardiovascular risk factors according to an online article published today by The Lancet.
› Verified 8 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The U.S. Food and Drug Administration today unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics.
More aggressive treatment with statins is necessary to lower LDL (low-density lipoprotein) cholesterol in patients with coronary heart disease and metabolic syndrome, a syndrome composing of three cardiovascular risk factors according to an online article published today by The Lancet.
› Verified 8 days ago
| Entity Name | Tower Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The U.S. Food and Drug Administration today unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics.
More aggressive treatment with statins is necessary to lower LDL (low-density lipoprotein) cholesterol in patients with coronary heart disease and metabolic syndrome, a syndrome composing of three cardiovascular risk factors according to an online article published today by The Lancet.
› Verified 8 days ago
| Entity Name | Blue Mountain Psychiatry, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679819908 PECOS PAC ID: 5496909376 Enrollment ID: O20130130000126 |
News Archive
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The U.S. Food and Drug Administration today unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics.
More aggressive treatment with statins is necessary to lower LDL (low-density lipoprotein) cholesterol in patients with coronary heart disease and metabolic syndrome, a syndrome composing of three cardiovascular risk factors according to an online article published today by The Lancet.
› Verified 8 days ago
| Entity Name | Dlp Conemaugh Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932515905 PECOS PAC ID: 7315166949 Enrollment ID: O20140915002522 |
News Archive
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The U.S. Food and Drug Administration today unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics.
More aggressive treatment with statins is necessary to lower LDL (low-density lipoprotein) cholesterol in patients with coronary heart disease and metabolic syndrome, a syndrome composing of three cardiovascular risk factors according to an online article published today by The Lancet.
› Verified 8 days ago
| Entity Name | Eastern Pennsylvania Physician Alliance, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902440621 PECOS PAC ID: 8325478662 Enrollment ID: O20200428001935 |
News Archive
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The U.S. Food and Drug Administration today unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics.
More aggressive treatment with statins is necessary to lower LDL (low-density lipoprotein) cholesterol in patients with coronary heart disease and metabolic syndrome, a syndrome composing of three cardiovascular risk factors according to an online article published today by The Lancet.
› Verified 8 days ago
| Entity Name | Reading Behavioral Healthcare, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750997466 PECOS PAC ID: 8527495183 Enrollment ID: O20201209001899 |
News Archive
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The U.S. Food and Drug Administration today unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics.
More aggressive treatment with statins is necessary to lower LDL (low-density lipoprotein) cholesterol in patients with coronary heart disease and metabolic syndrome, a syndrome composing of three cardiovascular risk factors according to an online article published today by The Lancet.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arif Husain, MD 235 Pine Top Trail, Bethlehem, PA 18017 Ph: (610) 217-3284 | Arif Husain, MD 3505 Western Ave, Kingman, AZ 86409-3071 Ph: (928) 757-8111 |
News Archive
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA).
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The U.S. Food and Drug Administration today unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics.
More aggressive treatment with statins is necessary to lower LDL (low-density lipoprotein) cholesterol in patients with coronary heart disease and metabolic syndrome, a syndrome composing of three cardiovascular risk factors according to an online article published today by The Lancet.
› Verified 8 days ago
Mr. Elias Omar Ruiloba, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2002 N Stockton Hill Rd, #104, Kingman, AZ 86401 Phone: 928-718-4800 Fax: 928-757-3256 | |
Dr. Sirpa A Tavakoli, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1743 Sycamore Ave, Kingman, AZ 86409 Phone: 928-757-8111 | |
Laurence David Seltzer, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 915 Airway Ave Ste A, Kingman, AZ 86409 Phone: 928-718-4800 | |
Dr. Laurence Schiff, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3931 Stockton Hill Rd, Kingman, AZ 86409 Phone: 928-681-2121 Fax: 928-681-2000 | |
Dr. Ernest Lavere Harman Jr., MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5036 Stockton Hill Rd, Kingman, AZ 86409 Phone: 928-377-1615 Fax: 928-692-1888 | |
Celia Rodriguez, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1741 Sycamore Ave, Kingman, AZ 86409 Phone: 928-757-8111 Fax: 928-757-3256 |